Novel approaches to therapeutics in pancreatic adenocarcinoma: vitamin C and tumor treatment fields  

作　　者：Laith Abushahin Travis Jones Jonathan Song Terence M.Williams Haseebah Shahzad Anne Noonan 

机构地区：[1]Arthur G.James Comprehensive Cancer Center and Richard J.Solove Research Institute,The Ohio State University Medical Center,Columbus,OH 43210,USA [2]Department of Internal Medicine,Division of Medical Oncology,The Ohio State University,Columbus,OH 43210,USA [3]Department of Mechanical&Aerospace Engineering,The Ohio State University,Columbus,OH 43210,USA [4]Department of Radiation Oncology,The Ohio State University Medical Center,Columbus,OH 43210,USA

出　　处：《Journal of Cancer Metastasis and Treatment》2021年第1期284-299,共16页癌症转移与治疗（英文版）

摘　　要：Pancreatic ductal adenocarcinoma(PDAC)is a lethal disease with limited therapeutic options.Despite extensive clinical research over the past several decades,meaningful improvements in care standards have been challenging to achieve.Research efforts are underway on several fronts,including cytotoxic chemotherapy combinations,immunotherapy,and targeted therapy.In this review,we chose to focus less on mainstream avenues of clinical research in PDAC and highlight some novel and innovative research efforts that are typically outside the spotlight of therapies.Examples of these novel approaches include pharmacologic vitamin C and electromagnetic fields.This review’s scope is to present the biological basis of the anti-cancer potential and the early clinical data,as well as the future landscape of these agents,including ongoing clinical trials in these therapeutic avenues.

关 键 词：Pancreas cancer vitamin C ASCORBATE tumor treatment fields induced electromagnetic field electromagnetic field therapy 

分 类 号：R73[医药卫生—肿瘤]